Supplementary Material for: A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease

Matthew R. Weir, Radmila Kančeva, Jogender Kumar et al.|Figshare|2017

Cited by 0